Hua Medicine
PublicLast Round
IPO Announced
Sep 14, 2018
Est. Valuation
$1.12B
Total Funding Raised
$374.74M
Company Overview
Hua Medicine (HKG: 02552) is a biopharmaceutical company focused on the development and commercialization of Dorzagliatin (HMS5552), a first-in-class oral medication for the treatment of Type 2 diabetes, primarily operating in the PRC.
Sector
Biotech
AI Layer
Non-AI
Keywords
dorzagliatin (HuaTangNing)first-in-class glucokinase activator (GKA)oral Type 2 diabetes drugglucose sensitivity restoration therapyType 2 diabetes treatment for Chinalow hypoglycemia risk diabetes drugmetabolic disease drug developmentsmall-molecule drug discoveryin-house drug R&Ddiabetes drug for chronic kidney disease patientscontract drug manufacturing modeldorzagliatin and metformin fixed-dose combinationParkinson's disease therapy development
Hua Medicine Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hua Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Sep 14, 2018 | ||||
| Series D | Mar 27, 2018 | ||||
| Series C | Apr 22, 2016 | ||||
| Series B | Jan 8, 2015 | ||||
| Series A | May 16, 2014 | ||||
Series A | Sep 20, 2011 |
Hua Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Guotai Junan Securities (Hong Kong) Limited | IPO |
| Harvest Global Investments | Series C |
| Frontline BioVentures | Series C, Series B |
| Harvest Global Investments | Series C, Series D |
| Blue Pool Capital | Series D |
| Ally Bridge Group | Series D, Series C, Series B |
| TF Capital | Series C, Series B |
Hua Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersShanghai, Shanghai
Year Founded2011
Last FundingSep 14, 2018